HTR4 and early-onset autosomal dominant Alzheimer disease: Due to its distinct cerebral distribution and physiological properties, 5-HT4R has emerged as a promising target for brain disorders such as depression, Alzheimer’s disease, eating disorders, and Parkinson’s disease [2,5,6,7,8].